TRURAPI DIN 02529254
Health Canada record
| Active ingredient(s) | INSULIN ASPART 100 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | A10AB05 INSULIN ASPART |
| Original market date | 03-Nov-2022 |
| Current status date | 03-Nov-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INSULIN ASPART
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02460408 | FIASP | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02460416 | FIASP | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02520982 | KIRSTY | BIOCON BIOLOGICS CANADA INC | Solution | INSULIN ASPART 100 UNIT | Approved |
| 02520974 | KIRSTY | BIOCON BIOLOGICS CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02265435 | NOVOMIX 30 | NOVO NORDISK CANADA INC | Suspension | INSULIN ASPART 30 UNIT; INSULIN ASPART PROTAMINE 70 UNIT | Marketed |
| 02244353 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02245397 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02506564 | TRURAPI | SANOFI-AVENTIS CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02506572 | TRURAPI | SANOFI-AVENTIS CANADA INC | Solution | INSULIN ASPART 100 UNIT | Marketed |
| 02460424 | FIASP | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Dormant |
| 02265443 | NOVOMIX 30 (FLEXPEN) | NOVO NORDISK CANADA INC | Suspension | INSULIN ASPART 30 %; INSULIN ASPART PROTAMINE 70 % | Cancelled Pre Market |
| 02377209 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | INSULIN ASPART 100 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 28634 | 2022-07-20 | Supplement to a New Drug Submission (SNDS) | New route of administration and new presentation |
International API supply for INSULIN ASPART
6 active FDA Drug Master Files.
Request a quote for TRURAPI